MEDP Medpace Holdings Inc

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

$177.90  +2.02 (1.15%)
As of 06/24/2021 15:59:42 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2016
Outstanding shares:  35,972,156
Average volume:  162,005
Market cap:   $6,576,069,838
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    58506Q109
ISIN:        US58506Q1094
Sedol:      BDCBC61
Valuation   (See tab for details)
PE ratio:   39.62
PB ratio:   7.32
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy